6,7-Dihydro-[1,2,3]triazolo[1,5-a]pyrazine-5(4H)-carboxylic acid tert-butyl ester

5-Boc-4,6,7-trihydro-1,2,3-triazolo[1,5-a]pyrazine was used in the synthetic preparation of a library of [1,2,3]-triazolopiperidine derivatives which were then screened to estimate their effectiveness in treating type 2 diabetes.